Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

2.090 USD -0.140 (-6.28%)
Official Closing Price Updated: 7:43 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adma Biologics

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
BRIEF-ADMA Biologics announces proposed public offering of common stock
* Adma Biologics announces proposed public offering of common stock Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780) 
Tags companyNews
From Reuters: Company News
ADMA Biologics Announces Proposed Public Offering of Common Stock
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
BRIEF-ADMA Biologics announces data on RI-002
* Announces data on RI-002 to be presented at the Clinical Immunology Society 2016 annual meeting 
Tags companyNews
From Reuters: Company News
ADMA Biologics Announces Data on RI-002 to be Presented at the Clinical Immunology Society 2016 Annual Meeting
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
BRIEF-Adma biologics reports FY loss per share of $1.73
* Adma biologics reports year end 2015 financial results, accomplishments and upcoming milestones 
Tags companyNews
From Reuters: Company News
ADMA Biologics Reports Year End 2015 Financial Results, Accomplishments and Upcoming Milestones
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China. 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
ADMA Biologics Announces Data Presented at 2016 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI)
Abstract titled: “A High Titer Anti-RSV Polyclonal Antibody (RI-002) Prevents Infection with Palivizumab Resistant RSV in Cotton Rats and Achieves Greater Neutralizing Anti-RSV Activity as Compared to... 
From GlobeNewswire News Releases
ADMA Biologics to Present at Cowen and Company 36th Annual Health Care Conference
ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
Biggest Movers in Manufacturing Stocks Now – AST KRO ADMA EYEG
 
Tags NYSE:TPUB NASDAQ:PRTA NASDAQ:OASM
From InvestorPlace
ADMA Biologics Recognized as One of New Jersey’s “Best Places to Work 2016”
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
14 Biotechnology Stocks to Sell Now
 
Tags Stocks to Sell NASDAQ:VNDA NASDAQ:EPZM
From InvestorPlace
The 2016 Small-Cap Biotech Watchlist Debuts At The Biotech Showcase
This may prove a challenging year for small-cap biotechs, but the five analysts who selected companies for inclusion on The Life Sciences Report's 2016 Small-Cap Biotech Watchlist believe these... 
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
16 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:CERU NASDAQ:TGTX NASDAQ:CGIX
From InvestorPlace
ADMA Biologics Expands Commercial Operations Team in Preparation for Commercial Launch of RI-002 in Second Half of 2016
ADMA Biologics, Inc. (Nasdaq:ADMA), announced today the expansion of its commercial operations team, appointing Alan Erck as the Company’s Vice President, Sales and National Accounts. ADMA Biologics is... 
From GlobeNewswire News Releases
ADMA Biologics to Present at the Oppenheimer 26th Annual Healthcare Conference
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
ADMA Biologics Reports Third Quarter 2015 Results
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
ADMA Biologics Announces Data to be Presented at the International Primary Immunodeficiencies Congress in Budapest Hungary
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
Biggest Movers in Manufacturing Stocks Now – GBX ADMA ANAC AVID
 
Tags NYSE:TROX NASDAQ:ITCI NASDAQ:ADMP
From InvestorPlace
Hottest Manufacturing Stocks Now – GIG FIT OFLX AGRX
 
Tags NASDAQ:OCUL AMEX:GIG NYSE:GBX
From InvestorPlace
Hottest Manufacturing Stocks Now – JAGX ANAC RLYP ACW
 
Tags NASDAQ:ADMA NYSE:ACW NYSE:HUN
From InvestorPlace
BRIEF-Biotest continues cooperation with ADMA Biologics for RSV Hyperimmunoglobulin RI-002
* Continues cooperation with ADMA Biologics, Inc. for RSV Hyperimmunoglobulin RI-002 
Tags companyNews
From Reuters: Company News
ADMA Biologics Receives Milestone Payment From Biotest AG for RI-002 BLA Submission to FDA
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
ADMA Biologics Recognized as One of the 50 Fastest Growing Companies in New Jersey
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
ADMA Biologics to Present at the Ladenburg Thalmann 2015 Healthcare Conference
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of... 
From GlobeNewswire News Releases
FDA Accepts ADMA Biologics License Application for RI-002
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics, announced that the U.S. Food and... 
From GlobeNewswire News Releases
ADMA Biologics Receives FDA Approval for Second Plasma Collection Center
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics, announced that the Company's... 
From GlobeNewswire News Releases
ADMA Biologics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
From GlobeNewswire News Releases
ADMA Biologics Receives Patent Issuance Pertaining to the Treatment of Immunodeficiency
Patent Coverage for RI-002 Immune Globulin (IG) in Immune Compromised PIDD Patients 
From GlobeNewswire News Releases
ADMA Biologics Reports Second Quarter 2015 Results
Provides Corporate Update and Anticipated Upcoming Milestones 
From GlobeNewswire News Releases
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.